CA3048156C - Anticorps de facteur xi et methodes d'utilisation - Google Patents

Anticorps de facteur xi et methodes d'utilisation

Info

Publication number
CA3048156C
CA3048156C CA3048156A CA3048156A CA3048156C CA 3048156 C CA3048156 C CA 3048156C CA 3048156 A CA3048156 A CA 3048156A CA 3048156 A CA3048156 A CA 3048156A CA 3048156 C CA3048156 C CA 3048156C
Authority
CA
Canada
Prior art keywords
amino acid
seq
acid sequence
antibody
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3048156A
Other languages
English (en)
Other versions
CA3048156A1 (fr
Inventor
Maximillian AIGNER
Alexander Wolfgang KOCH
Markus WALDHUBER
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority claimed from PCT/IB2017/058312 external-priority patent/WO2018116255A1/fr
Publication of CA3048156A1 publication Critical patent/CA3048156A1/fr
Application granted granted Critical
Publication of CA3048156C publication Critical patent/CA3048156C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne des anticorps monoclonaux et leurs fragments de liaison à l'antigène qui se lient au facteur XI humain et au facteur XI activé ("Facteur XIa"), ainsi que des compositions pharmaceutiques et des procédés de traitement les comprenant.
CA3048156A 2016-12-23 2017-12-21 Anticorps de facteur xi et methodes d'utilisation Active CA3048156C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662438648P 2016-12-23 2016-12-23
US62/438,648 2016-12-23
PCT/IB2017/058312 WO2018116255A1 (fr) 2016-12-23 2017-12-21 Anticorps de facteur xi et méthodes d'utilisation

Publications (2)

Publication Number Publication Date
CA3048156A1 CA3048156A1 (fr) 2018-06-28
CA3048156C true CA3048156C (fr) 2026-01-06

Family

ID=

Similar Documents

Publication Publication Date Title
US20240067750A1 (en) Factor xi antibodies and methods of use
US12012464B2 (en) Factor XI antibodies and methods of use
EP3464383B1 (fr) Agents d'inversion de liaison pour anticorps antifacteur xi/xia et utilisations correspondantes
CA3083210A1 (fr) Agents d'inversion de liaison pour anticorps antifacteur xi/xia et utilisations correspondantes
CA3048156C (fr) Anticorps de facteur xi et methodes d'utilisation
HK40117191A (en) Reversal binding agents for anti-factor xi/xia antibodies and uses thereof